Maintenance / Service
PRODUCTS
-
Digital health technologies have the potential to transform clinical trials, yet without careful planning and operational support, their implementation can create complexity, increase site burden, and jeopardize data quality.
-
The PermaNET SU leak detection loggers are a key part of our product lineup. These loggers function as acoustic sensors attached to the external surface of clean water distribution pipes. The leak detection process involves two main steps: first, the loggers measure the noise level emitted by the pipes and then evaluate it against a predefined threshold. Made in America and winner of the Environmental Protection Award, these loggers exemplify top-notch quality and reliability.
-
Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.
-
Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.
-
A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.
WHITE PAPERS AND CASE STUDIES
-
Endpoint Clinical RTSM: Getting The Job Done
Explore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.
-
Automating Cell Therapy Manufacturing And Enabling Rapid Multi-Site Tech Transfer
Find out how automating cell therapy manufacturing with a flexible platform can improve biological performance, streamline tech transfer, and support regulatory confidence for scalable, multi-site production.
-
Enhancing Clinical Trial Flexibility
Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.
-
Recruitment To Screening: Bridging The Gap
Explore how providing tracked transportation for patients can streamline recruitment, improve site conversion rates, and deliver measurable ROI for clinical trials.
-
Unlock The Power Of Clinical Data Science
Discover a unified, AIādriven approach that helps clinical teams manage growing data complexity, accelerate insight generation, and improve trial oversight to enable faster decisions.
-
Leading European CDMO For Drug Product Manufacturing
As timelines tighten and regulatory demands grow, discover how a European CDMO delivers integrated solutions from aseptic fill and finish to packaging and release.
-
Outgrowing Excel: Implementing RTSM In A Live Phase I Trial
Learn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
-
Quantitation Of Monoclonal Antibodies In Serum
Monoclonal antibodies (mAbs) are a rapidly growing group of targeted therapeutics. Gain insight into the importance of optimized bioanalytical assay platforms for mAb development.
-
AI-Driven Signal Management: The Future Of Drug Safety
By combining autonomy with robust governance, agentic AI enables pharmacovigilance teams to move from reactive to proactive safety management, anticipating risks before they materialize.
-
The Digital Transformation Of A Leading CDMO's Process Development Lab
Discover how a leading CDMO was able to create a data model for its bioreactors, resulting in easily contextualized data, time savings in manual tasks, and the ability to share insights in real time.
-
Therapeutic Radiopharmaceuticals: Clinical Research, CRO Enablers (2025)
Accelerate the future of precision oncology by driving innovation, optimizing clinical development, and expanding access to targeted therapies that transform patient outcomes.
-
Providing Enhanced Manufacturing Data To Contracting Companies
The life sciences sector is projected to reach $220 billion by 2030. Examine the growth of CDMOs and CMOs, emphasizing the need for digitalization to meet client demands and regulatory standards.
NEWS
-
Neochromosome And Opentrons Introduce Automated Antibody Discovery Solution, Enabling Labs To Achieve Rapid, Cost-Effective In-House Development4/29/2025
Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its subsidiary specializing in products unlocked through genome-scale cell engineering, today announced the Opentrons Flex neoSwitch Workstation powered by the Neochromosome neoSwitch platform for in-house antibody discovery.
-
Mayo Clinic Laboratories And Amprion Announce Collaboration To Advance Neurodegenerative Disease Diagnostics3/26/2025
Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States.
-
Immundiagnostik To Highlight Innovative Detection Tools At 2025 ADLM Clinical Lab Expo7/15/2025
Immundiagnostik, Inc., along with its parent company Immundiagnostik AG (Bensheim, Germany), is pleased to announce its upcoming participation at the 2025 ADLM Clinical Lab Expo in Chicago, July 29–31.
-
GovSignals Extends AI-Powered Workflow Solution To Government Agencies With Multi-Million Dollar DIU Contract Win, Advances FedRAMP & IL5 Readiness3/18/2025
GovSignals, the first AI platform to automate the full process of finding and bidding on government contracts, announced today its expansion from supporting government contractors to directly serving government agencies.
-
Fischer Mechanical Partners With Byrne Software And Runding Corporation To Modernize Project Delivery And Field Operations8/19/2025
Fischer Mechanical, a fast growing St. Louis-based mechanical contractor, has selected Byrne Software Technologies in partnership with Runding Corporation to support its digital transformation initiative aimed at improving labor productivity, standardizing workflows, and enabling real-time job cost insights.